# 2026-23204: CDC Asks How Quickly a West Nile Test Should Work

2026-23204, Target Product Profile for a Rapid Diagnostic Test for West Nile Virus Disease: Request for Information, is a Federal Register notice from Health and Human Services Department, Centers for Disease Control and Prevention published 2026-11-16, effective 2027-01-15 (as of 2026-11-17).

- Canonical: https://policyrisk.com/federal-register/2026-23204
- As of: 2026-11-17
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-23204
- Title: Target Product Profile for a Rapid Diagnostic Test for West Nile Virus Disease: Request for Information
- Type: Notice
- Agencies: Health and Human Services Department; Centers for Disease Control and Prevention
- Citation: 91 FR 73597
- Published: 2026-11-16
- Effective: 2027-01-15
- Comments close: 2027-01-15
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-11-17

## In one line

CDC Asks How Quickly a West Nile Test Should Work

## Summary

The CDC wants your ideas to help create a fast and easy test for West Nile Virus that hospitals and labs can use. This new test could speed up diagnosis and help people get treated quicker. If you have thoughts, send them in by January 15, 2027, so the CDC can make the best test possible!

## Abstract

The Centers for Disease Control and Prevention (CDC) in the Department of Health and Human Services (HHS) announces the opening of a docket to obtain comment on the proposed Target Product Profile for a Rapid Diagnostic Test for West Nile Virus Disease for Use in Hospitals and Clinical Laboratories. This Request for Information (RFI) invites comments and suggestions on the proposed target product profile. HHS/ CDC is publishing this target product profile to improve the likelihood of developing a commercially available diagnostic assay that can be used to rapidly diagnose West Nile virus infection. Public input is a valuable component in developing a useful target product profile.

## Effects PRIA read

No economic effects identified for this document.

## Related documents

- [2026-23004](https://policyrisk.com/federal-register/2026-23004): Final Effect of the Designation of a Class of Employees for Addition to the Special Exposure Cohort, 2026-11-12
- [2026-22881](https://policyrisk.com/federal-register/2026-22881): Proposed Data Collection Submitted for Public Comment and Recommendations, 2026-11-10
- [2026-22819](https://policyrisk.com/federal-register/2026-22819): Agency Forms Undergoing Paperwork Reduction Act Review, 2026-11-09
- [2026-22775](https://policyrisk.com/federal-register/2026-22775): Meeting of the Advisory Board on Radiation and Worker Health, National Institute for Occupational Safety and Health, 2026-11-09
- [2026-22330](https://policyrisk.com/federal-register/2026-22330): Agency Forms Undergoing Paperwork Reduction Act Review, 2026-11-02
- [2026-22329](https://policyrisk.com/federal-register/2026-22329): Agency Forms Undergoing Paperwork Reduction Act Review, 2026-11-02

## Sources
- [2026-23204 on federalregister.gov](https://www.federalregister.gov/documents/2026/11/16/2026-23204/target-product-profile-for-a-rapid-diagnostic-test-for-west-nile-virus-disease-request-for)
- [2026-23204 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-11-16/pdf/2026-23204.pdf)

## Related
- [Previous: 2026-23203, Agency Information Collection Activities: Notice of Intent To Extend Collection…](https://policyrisk.com/federal-register/2026-23203)
- [Next: 2026-23205, Target Product Profile for Monoclonal Antibodies for West Nile Virus Disease Pr…](https://policyrisk.com/federal-register/2026-23205)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-23204 (as of 2026-11-17).
